First Treatment Approved for Eosinophilic Esophagitis

(MedPage Today) -- Dupilumab (Dupixent) became the first drug approved to treat eosinophilic esophagitis in adults and pediatric patients ages 12 and older weighing at least 40 kg (~88 lb), the FDA announced. Eosinophilic esophagitis is a chronic...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news